Trastuzumab Unknown Status Phase 3 Trials for Breast Cancer Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Unknown Status | Treatment | 3 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT00045032 | Trastuzumab in Treating Women With Primary Breast Cancer | |
| NCT00712140 | Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer | |
| NCT00629278 | Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer | |
| NCT00430001 | Vinorelbine Plus (+) Trastuzumab vs Docetaxel Plus (+) Trastuzumab as 1 Line Treatment for HER2 Positive (+) Metastatic Breast Cancer |